期刊文献+

血管内皮生长因子受体-1和COX-2在胃癌中的表达及临床意义 被引量:4

Expression and clinical significance of Flt-1 and COX-2 in gastric cancer
下载PDF
导出
摘要 目的研究血管内皮生长因子受体-1(Flt-1)和环氧合酶-2(COX-2)在胃癌中的表达及其临床意义。方法选择80例手术切除的胃癌标本为观察组,30例胃癌旁、40例慢性非萎缩性胃炎组织为对照组,应用免疫组织化学方法检测组织中Flt-1及COX-2的蛋白表达。结果Flt-1及COX-2在胃癌中的表达率均为52.5%,在癌旁及对照组的阳性率分别为13.3%、0%、7.5%、0%,差异均有统计学意义(P<0.01),二者的表达与胃癌的TNM分期及浸润呈正相关,它们的阳性表达强度与肿瘤淋巴及血道转移呈正相关(P<0.05),与肿瘤大小、分化程度无关(P>0.05)。Flt-1、COX-2在胃癌组织中表达呈正相关(γ=0.608,P=0.000)。结论Flt-1、COX-2参与胃癌的发生、发展,二者在胃癌的发生、浸润转移中可能存在相互协同作用,联合检测Flt-1、COX-2可作为胃癌浸润、转移的重要判定指标。 Objective To investigate the expression and clinical significance of vascular growth factor reeeptor-1 (Flt-1) and COX-2 in gastric cancer. Methods Tissue section from 80 gastric cancer(GC) ,30 tissue section from side gastric cancer,40 chronic non -atrophy gastritis tissue were examined by using immunohistochemistry for the expression of Flt-1 and COX-2. Results The positivity rates of Flt-1 and COX-2 were both 52.5% ,which were significantly higher than that in patients with side gastric cancer and chronic non -atrophy gastritis tissue(13. 3% .0% .7.5% ,0%, P〈0.01〉. The high positive expression of two indexes had positive correlation with regional invasion and lymphatic and blood stream metastasis in GC, But had no correlation with the size and differentiation degree. There was significant correlation between the expression of Flt-1 and COX-2. Conclusion Flt-1 and COX-2 might be associated with the development of gastric cancer. The two indexes may pay coordination role in anginogenesis,invasion in gastric cancer.
出处 《重庆医学》 CAS CSCD 北大核心 2010年第8期919-920,929,共3页 Chongqing medicine
关键词 胃肿瘤 血管内皮生长因子受体-1 环氧合酶-2 gastric neoplasms Flt-1 COX-2
  • 相关文献

参考文献10

  • 1刘东屏,王炳元,姜若兰.胃癌组织内血管内皮生长因子及其受体Flt、KDRmRNA的表达[J].中华消化杂志,2000,20(4):252-254. 被引量:19
  • 2王元宇,叶再元,赵仲生,陶厚权.胃癌组织血管内皮细胞生长因子及其受体Flt-1的表达及与胃癌生物学行为的关系[J].中华胃肠外科杂志,2007,10(3):269-273. 被引量:5
  • 3Pallares J,Rojo F,Iriarte J,et al.Study of mierovessel density and the expression of the angiogenic factors VEGF,bFGF and the receptors Flt-1 and FLK-1 in benign,premalignant and malignant prostate tissues[J].Histol Histopathol,2006,21:857.
  • 4Lesslie DP,Summy JM,Parikh NU,et al.Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases[J].Br J Cancer,2006,94:1710.
  • 5Roberts DM,Kearney JB,Johnson JH,et al.The vascular endothelial growth factor(VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation[J].Am J Pathol,2004,164:1531.
  • 6Singh B,Berry JA,Shoher A,et al.COX-2 overexpression increases motility and invasion of breast cancer cells[J].Int J On Col,2005,26:1393.
  • 7Eibl G,Takata Y,Boros LG,et al.Growth stimulation of COX-2 negative pancreatic cancer by a selective COX-2 inhibitor[J].Cancer Res,2005,65:982.
  • 8Ranger GS,Thomas V,Jewell A,et al.Elevated cycoxygenase-2 expression correlates with distant metastases in breast cancer[J].Anticancer Res,2004,24(4):2349.
  • 9Shiotani H,Denda A,Yamamoto K,et al.Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline1-oxid-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor,nirnesviide[J].Cancer Res,2001,6l(4):1451.
  • 10Cheng AS,Chan HL,Tok F.Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis-B virus associated hepatocellular carcinoma[J].Int J On Col,2004,24(4):853.

二级参考文献20

  • 1赵仲生,姚根有,茹国庆,马杰,阮俊.碱性成纤维细胞生长因子和基质金属蛋白酶-9mRNA表达与胃癌临床病理学及生存期的关系[J].中华外科杂志,2005,43(3):169-173. 被引量:6
  • 2Pallares J, Rojo F, Ifiarte J, et al. Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues. Histol Histopathol, 2006,21 : 857-865.
  • 3Chen H, Ye D, Xie X, et al. VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma. Gynecol Oncol, 2004,94 : 630-635.
  • 4Ng IO, Poon RT, Lee JM, et al. Microvessel density, vascular endothelial growth factor and its receptors Fh-1 and FIk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol, 2001,116 : 838-845.
  • 5Wey JS, Fan F, Gray M J, et al. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer, 2005,104 : 427-438.
  • 6Meunier-Carpentier S, Dales JP, Djemli A, et al. Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma. Int J Oncol, 2005,26 : 977-984.
  • 7Suhardja A, Hoffman H. Role of growth factors and their receptors in proliferation of microvascular endothelial cells. Microsc Res Tech, 2003,60 : 70-75.
  • 8Karkkainen M J, Petrova TV. Vascular endothelial growth factor receptors in regulation of angiogenesis and lymphangiogenesis. Oncogene, 2000, 19 : 5598-5605.
  • 9Hiratsuka S, Maru Y, Okada A, et al. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1 ) in pathological angiogenesis. Cancer Res, 2001,61 : 1207-1213.
  • 10Roberts DM, Kearney JB, Johnson JH, et al. The vascular endothelial growth factor (VEGF) receptor Flt- 1 (VEGFR- 1 ) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. Am J Pathol, 2004, 164: 1531-1535.

共引文献22

同被引文献39

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部